Table of contents
- See also VitaminDWiki: Random Controlled Trials with vitamin D intervention
- See also VitaminDWiki
- Vitamin D is especially needed during pregnancy
- Also, The Vitamin D Receptor limits the amount of Vitamin D in the blood actually gets to the tissue
- Want a LOT more data on Vitamin D treating early COVID or preventing health problems
- Saudi Arabia is funding longevity etc - but I got many negative comments about helpint them
- Getting data on results of intervention
- On the Large Scale Plans of the Hevolution Foundation - June 2022
- Health + Evolution = hevolution
- VitaminDWiki pages with SAUDI in the title (18 as of July 2022)
- VitaminDWiki - Middle East and Vitamin D contains
149 items in Middle East category
- see also Overview Middle East and vitamin D
- VitaminDWiki - Longevity
- China summary: Sent 6 letters to Dr. Shen but got Zero response. so I gave up
- China's Zero COVID policy: the best tracking data on the planet
- Quarantine time and locations changed June 29, 2022
- Just the cost of testing: >$34 Billion for 2022
- There have been
1359 visits to this page
- Cancer mortality reduced 40 pcnt by 2000 IU Vitamin D daily if normal weight – Meta-analysis June 2022
- 4 X fewer visits to Dr. after getting high level of vitamin D (Interview with transcript) - Jan 3, 2022
- COVID-19 mortality extrapolates to zero at 50 ng of vitamin D – 18th Meta-analysis Sept 2021
- Does Less Sun mean More Disease video mentions his experience
- COVID, Cancer, etc. are Vitamin D low-hanging-fruit – Editorial June 2022
- Chance of dying in hospital cut in half by just 10 ng higher level of Vitamin D – April 2016
- Turkey gave 400 IU vitamin D to all infants and reduced Rickets by 60X - 2011
- Fortification with Vitamin D works – 16 studies of Danish experience – July 2021
- Proof that Vitamin D Works has the following list
ADHD, Alcoholic Liver Cirrhosis, ALS, Alzheimer's, Antibiotic Use in Seniors, Asthma, Autism, Autoimmune Diseases, Back pain, Blood Cell Cancer, Breast Cancer, Cardiovascular, Cholesterol, Chronic Hives, Chronic Kidney Disease, Cluster Headaches, Congestive Heart Failure (Infants), COPD, Crohn's Disease, C-Section and Pregnancy Risks, Cystic Fibrosis, Depression, Diabetes, Diabetic Neuropathy, Eczema, Falls, Fatigue, Fatty Liver (Child), Fibromyalgia, Gestational Diabetes, Gingivitis, Growing Pains, Hay Fever, Heart Attack, Hemodialysis, Hepatitis-C, Hip Fractures, Hypertension, Influenza, Irritable Bowel Syndrome, Ischemic Stroke, Knee Osteoarthritis, Leg Ulcers, Low Birth Weight, Lupus, Male Infertility, Menstrual Pain, Metabolic Syndrome, Middle Ear Infection (Infants), Mite Allergy, Multiple Sclerosis, Non-Alcoholic Fatty Liver Disease, Osteoarthritis, Parkinson's Disease, Perinatal Depression, Pneumonia (Ventilator-associated), Poor Sleep, PreDiabetes, Preeclampsia, Pre-term Birth, Prostate Cancer, Quality of Life, Raynaud's Pain, Respiratory Tract Infection, Restless Leg Syndrome, Rheumatoid Arthritis, Rickets, Sarcopenia, Sepsis, Short Neonates, Sickle Cell, Stronger Senior Muscles, Survive ICU, TB, Trauma Death, Traumatic Brain Injury, Tuberculosis, Ulcerative Colitis, Urinary Tract Infection, Vaginosis, Vertigo, Warts, Weight Loss
Select pink box in the upper right to select a language
Click on underlined items for details
Health Problem Treat
Reduction by Vit D RCT = Randomized Controlled Trial
* = link to additional RCT
CT = Clinical Trial
149 to 142 mm Hg
HT risk reduced 10X
RCT* *, 2400 IU. 100,000 IU*
When Vitamin D > 40 ng
Cardiovascular after attack T 32 % fewer deaths CT 1000 IU Diabetes Type 1 P 85 % 12,000 kids, 2000 IU Diabetes Type 2 T 62 % RCT* CRP reduction, 4000 IU
Injection is far better - RCT *
RCT 50,000 IU/2weeks + probiotics
RCT 5,000 IU daily 6 months
Back Pain T 95 %
60,000 IU weekly
Influenza P 90 % RCT *, 2000 IU Falls P 50% RCT, 100,000 IU monthly
RCT with Meals on Wheels 2016
Hip Fractures P 30 % RCT * 800 IU Rickets P 98 % Turkey, 400 IU
NOT RCT, given to all children
Raynaud's Syndrome T 40 % RCT, visual scale, 20000 IU Avg Menstrual pain P 76 % RCT, 7000 IU Avg,
70% reduction 2018
PMS reduced by half
Pregnancy risks P 50 % RCT, 4000 IU C-section, unplanned P 50 % RCT, 4000 IU, small study Low birth weight P 60 % RCT * 1000 IU of D2 TB P 60 % RCT, 800 IU Breast Cancer P 60 % RCT, 1100 IU (2007) Rheumatoid Arthritis pain T 40 % RCT, 500 IU, added to prescription Cystic Fibrosis T 75 %
2nd study improved
RCT, pilot 4X fewer deaths 250,000 IU
RCT, pilot 8,200 IU
Chronic Kidney T 90 to 70 PTH RCT, 3500 IU, Respiratory Tract Infection P 63 % 3 RCT, 4000 IU 1 year 2nd 2000/800 IU
20,000 IU weekly
Loading then 100,000 IU monthly,
RCT 4,000 IU
Sickle Cell T Less pain RCT, up to 100,000 IU/week Leg ulcer healing T 4X faster RCT, 50,0000 IU/week, small study Traumatic Brain Injury T 2X RCT, 20,0000 IU/day with progesterone Parkinson's Disease T Stabilized RCT, 1200 IU/day Multiple Sclerosis P
95% were CURED
RCT, 7100 IU prevent pre-MS ==> MS
20,000 to 140,000 IU/day
Congestive Heart Failure T 90 % RCT, 1000 IU infants (also: Adults, not RCT) Middle Ear Infection P 30 % RCT, 1000 IU infants Gingivitis T 88 % RCT, 2000 IU Muscle in seniors T 17 % more muscle RCT, 4000 IU Antibiotic use when >70y T 47 % RCT, 60,000 IU monthly Infants taller Benefit 1 cm tall RCT, 50,000 IU weekly,
for 8 weeks while pregnant
Gestational Diabetes T Reduced 3X RCT, 2 doses of 50,000 IU After Heart Attack T +6% ejection fraction RCT, 800,000 IU one time Prostate Cancer T Fewer +cores RCT, 4000 IU (2012) Asthma P T Reduced symptoms RCT, 60K IU/month;
RCT 50K IU/week
Need good D at 4 weeks into preg.
Depression T Reduced RCT 300,000 IU injection
RCT 1500 IU helped Prozac
RCT 50,000 IU weekly, elderly
Low vitamin D
P All infants > 20 mg RCT, 5,000 IU Fibromyalgia T Half of many still has Fibro RCT, 30-48 ng
RCT 50K IU/week
Hives, Chronic T Reduced 40% RCT, 4000 IU added Cholesterol T Reduced 4 mg RCT, 400 IU + Ca Weight Loss T lost 5 more lbs RCT, 2000 IU +diet +exercise Gestational Diabetes P 40% RCT * , 5,000 IU Chronic Obstructive
T 17X improvement CT, 50,000 IU weekly
RCT 100,000 IU monthly
Asthma T 1/2 Asthma attacks RCT >42 mg of vitamin D Quality of Life (QoL) T Nursing Home QoL CT, 4,000 IU in daily bread Death of Critically Ill
T 20% increase in survivability RCT 540 K IU loading than 90K monthly Restless Leg Syndrome T Score 26 ==> 10 CT, Vitamin D dose size
not stated in abstract
Hepatitis-C T Aided normal drugs RCT 2.000 IU Crohn's disease T improved when > 30 ng
2nd study fewer relapses
RCT 2,000 IU
10,000 IU RCT
Pre-term birth P 2.5X decrease, also: fewer
c-section & better Apgar
RCT 2,000 IU India Cluster headaches T CH eliminated in 60% 10,000 IU, Mg, Omega-3, etc Autism T 80% improved CT 300 IU/kg/day for 3 months PreDiabetes T ~20% reduced RCT 60,000 IU/month Weight loss:
Overweight and Obese
T 12 lbs in 6 months RCT 100,000 IU/month Sarcopenia = muscle loss T 27% increase RCT 1,000 IU Growing Pains T 60% decrease ~100,000 IU/month -NOT RCT
2nd study, similar results
Osteoarthritis pain T 60% decrease 50,000 IU/weekly - NOT RCT ALS T helped 2,000 IU - NOT RCT, given to all Vertigo T 3X reduction if raised > 10ng 600,000 IU load, then maint.
NOT RCT, given to all
Warts T 80% eliminated injection NOT RCT
Metabolic Syndrome P reduced 44% when VitD
increased by 30 ng
NOT RCT, given to all Hay fever P reduced 48% RCT 1,000 IU for 30 days Preeclampsia P Recurrance cut in half
3 RCT 3.6 X less likely if > 30 ng
50,000 IU every 2 weeks
4,000 IU daily
Blood cell cancer
T Survival 90% vs 50% 10,000 IU/week
NOT RCT, given to all
Irritable Bowel Syndrome T Reduced 3,000 IU spray RCT Urinary Tract Infection P 50% reduction RCT 20,000 IU weekly Mite Allergy P 5X reduction RCT 2,000 IU preg, 800 IU child Perinatal depression
(depression near birth)
T 50% reduction RCT 2,000 IU for just a few weeks Vaginosis T 10X reduction RCT 2,000 IU Eczema T Reduced 2 RCT 1,600 IU Non-Alcoholic
Fatty Liver Disease
T Reduced RCT 20,000 IU weekly Knee Osteoartiritis T Pain Reduced RCT 60,000 IU monthly after loading dose Tuberculosis T Faster Recovery RCT single 450,000 IU dose Stroke - Ischemic T Faster Recovery RCT single 600,000 IU injection
RCT single 300,000 IU injection
Sepsis T Reduce ICU and Hospital
length of stay by 7 days each
RCT 400,000 IU Trauma deaths T 50% fewer deaths Vitamin D & Glutamine
NOT RCT, given to all
Hemodialysis patients T helped 50,000 IU weekly NOT RCT, given to all Fatty liver - child T 2 X reduction RCT Vitamin D & DHA Fatigue T Reduced 100,000 IU single dose
NOT RCT, given to all
Sleep Disorders T Nicely treated RCT 50.000 IU bi-weekly Pneumonia
T RCT Death rate cut in half 300,000 IU injection Infertile males T birth rate doubled RCT 300,000 IU + maint Waist size T Waist size reduced 3 cm 100,000 IU loading + maint for 6 months
for those with Metabolic Syndrome
NOT RCT, given to all
RCT 3,000 IU for 12 weeks
RCT 50,000 IU weekly
Alcoholic liver cirrhosis T improved survival 1,000 IU of vitamin D NOT RCT Diabetic nephropathy T Reduced HOMA-IR, FRS RCT 50,000 IU weekly Ulcerative Colitis T Reduced 60% RCT 50,000 IU nano daily for a week Obese weight loss T Lost 3X more pounds $10 of Vitamin D added to
calorie restriction & walking
Endometriosis T Nicely treated RCT 50.000 IU bi-weekly Diabetic Wounds T 4X more likely to heal RCT 6,400 daily Alzheimer's T Often reverse Each person gets a different amount of
Vit D, Omega-3, B12, Iron, etc
Autoimmune P Decrease 30% RCT Vit D + Omega-3 Smoking T reduce problems RCT 50,000 bi-weekly
Most proofs are RCT (Randomized Controlled Trials), where not even the doctor knows who gets it vitamin D
- 2 are meta-analysis of multiple RCTs
- Vitamin D was given to ALL infants in the entire country (Rickets) - not an RCT
- In several studies researchers felt that it was unethical to not give vitamin D to everyone
- In some studies the dose size varied with the needs of the person (overweight, etc)
- In some studies the COFACTORS were adjusted with the needs of the patient%
- Curing requires the dose size and cofactors to be adjusted to the needs of each patient.
Many Clinical Trials have not found a benefit because of one or more of the following failures:
- Fails to use a large enough dose of vitamin D (often < 1,100 IU)
The Even larger dose needed if: 1) obese, 2) poor gut, 3) sick (many diseases consume lots of vitamin D)
- Fails to have given vitamin D for a long enough time (a few RCT lasted less than 5 weeks)
- Fails to have given Vitamin D frequently enough. At least every 2 months for D3) - and at least weekly for D2
Note: Infrequent dosing also causes unbalancing of the body's chemistry
- Fails to provide a loading dose, or had too short a duration to restore the vitamin D levels
- Fails to use D3 form, instead uses the less effective D2 form
- Fails to have a healthy range of Calcium or other important cofactors (especially for bone-related trials
Also, differences in Magnesium can result in 30% change in response to vitamin D
Magnesium is dependent on water, food, supplements
- Fails to notice the pre-existing vitamin D levels - only those who are low will likely show a benefit
- Fails to notice how/when the vitamin D was taken (which can change the response by as much as 2X)
- Fails to report on compliance (in one case 40% of the participants did not take the supplements consistently)
Many Meta-Analyses also do not find a benefit because one or more of the above failures
In addition, many meta-analysis average together ALL of the trials
Imagine a story about a meta-analysis of aspirin (which has never been done)
There would be scores of RCT for aspirin not working with 3 mg doses
There would be a many RCT of aspirin not working with 30 mg doses
There would be a few studies of aspirin WORKING with 300+ mg doses
There would be many studies of small amounts of Willow bark (Vitamin D2 instead of Vitamin D3)
Then there would be a meta-analysis of aspirin and Willow Bark
- That meta-analysis would conclude that aspirin and Willow bark do not work.
While about 200 RCTs will be published during 2014, I anticipate only adding 50 to the proofs table due to the reasons listed above
Also, some trials will not get started due to lack of people willing to go for years with < 500 IU of vitamin D
- Intervention - Vitamin D
- Note: It sorts the interventions by health problem as well as by date
- Vitamin D intervention trials - a long list - May 2014 1204 trials
2176 Vitamin D clinical trials as of June 2020: Nutrition Disorders 621, Vitamin D Deficiency 619, Malnutrition 601, Avitaminosis 586, Deficiency Diseases 583, **Metabolic Diseases 489. Musculoskeletal Diseases 362, Bone Diseases 317. Bone Diseases, Metabolic 282, Endocrine System Diseases 241. Osteoporosis 209, Immune System Diseases 190, Kidney Diseases 168, Communicable Diseases 164. Infection 164
- Update Nov 2022 2643 Clinical Trials with Vitamin D
- Systematic Reviews or Meta-Analysis of Vitamin D
- 137 health problems associated with low vitamin D – meta-meta-analysis April 2014
- Intervention - 2-30 days
- Overview: Vitamin D also TREATS
- Is it ethical to not give vitamin D in osteoporosis trials– NEJM Sept 2010
- Some Vitamin D RCT are not being created because the researchers do not want to deprive the benefits to half of the patients
- Some Vitamin D RCT cannot be started because too many candidates are already taking vitamin D
- Reasons for Vitamin D deficiency
- List of all categories of Vitamin D Information and number of items in each
- List of all Overviews of Vitamin D
76 items along with related searchesProblem Reduces Evidence 0. Chance of not conceiving 3.4 times Observe 1. Miscarriage 2.5 times Observe 2. Pre-eclampsia 3.6 times RCT 3. Gestational Diabetes 3 times RCT 4. Good 2nd trimester sleep quality 3.5 times Observe 5. Premature birth 2 times RCT 6. C-section - unplanned 1.6 times Observe Stillbirth - OMEGA-3 4 times RCT - Omega-3 7. Depression AFTER pregnancy 1.4 times RCT 8. Small for Gestational Age 1.6 times meta-analysis 9. Infant height, weight, head size
within normal limits
RCT 10. Childhood Wheezing 1.3 times RCT 11. Additional child is Autistic 4 times Intervention 12.Young adult Multiple Sclerosis 1.9 times Observe 13. Preeclampsia in young adult 3.5 times RCT 14. Good motor skills @ age 3 1.4 times Observe 15. Childhood Mite allergy 5 times RCT 16. Childhood Respiratory Tract visits 2.5 times RCT
RCT = Randomized Controlled Trial
Also, The Vitamin D Receptor limits the amount of Vitamin D in the blood actually gets to the tissue
The risk of 45 diseases at least double with poor Vitamin D Receptor as of Nov 2022
- China provides an opportunity to give Vitamin D to 1,000's who have either tested positive or have been near someone who has tested positive
- Saudi Arabia might provide the funds to give vitamin D to everyone in a small city and record how many fewer medical visits there were later
Note: A previous informal study causes us to guess there will be a 2X reduction in all medical visits.
Might be able to access Medical Records - at least # of doctors' visits
- Electronic medical records and health care promotion in Saudi Arabia - 2020 PDF
- Performance, Barriers, and Satisfaction of Healthcare Workers Toward Electronic Medical Records in Saudi Arabia: A National Multicenter Study - Feb 2022 PDF
- Exploring Facilitators to the Implementation of Electronic Health Records in Saudi Arabia - March 2022 PDF
Anyone who has more money than they know what to do with eventually tries to cure aging. Google founder Larry Page has tried it. Jeff Bezos has tried it. Tech billionaires Larry Ellison and Peter Thiel have tried it. Now the kingdom of Saudi Arabia, which has about as much money as all of them put together, is going to try it. The Saudi royal family has started a not-for-profit organization called the Hevolution Foundation that plans to spend up to $1 billion a year of its oil wealth supporting basic research on the biology of aging and finding ways to extend the number of years people live in good health, a concept known as "health span."
The foundation hasn't yet made a formal announcement, but the scope of its effort has been outlined at scientific meetings and is the subject of excited chatter among aging researchers, who hope it will underwrite large human studies of potential anti-aging drugs. The idea, popular among some longevity scientists, is that if you can slow the body's aging process, you can delay the onset of multiple diseases and extend the healthy years people are able to enjoy as they grow older. The fund is going to give grants for basic scientific research on what causes aging, just as others have done, but it also plans to go a step further by supporting drug studies, including trials of "treatments that are patent expired or never got commercialized."
The fund is authorized to spend up to $1 billion per year indefinitely, and will be able to take financial stakes in biotech companies. By comparison, the division of the US National Institute on Aging that supports basic research on the biology of aging spends about $325 million a year. Hevolution hasn't announced what projects it will back, but people familiar with the group say it looked at funding a $100 million X Prize for age reversal technology and has reached a preliminary agreement to fund the TAME trial, a test of the diabetes drug metformin in several thousand elderly people.
Health + Evolution = hevolution
- "We believe every human has the right to live a longer, healthier life"
- "Every person should live better – not just longer. This purpose can, with the right incentives from Hevolution, bring together the brightest and best scientific and business talent worldwide to reshape age in terms of opportunity, not decline."
I was given an outstanding opportunity to build Hevolution Foundation, a pioneering new organization with a laser-like focus on dramatically improving a condition that affects every human on the planet: aging.
Our mission is to drive efforts to extend healthy human lifespan, or healthspan, and to better understand the processes of aging, because the simple truth is: we all age; but we do not all age equally.
As a scientist, physician, and human being, I have seen that the experience of aging is not sufficiently improving. The number of individuals with chronic diseases has increased, despite average lifespan lengthening. We live longer, but we do not necessarily live better. As the world population grows, the population of the elderly grows as well, leading to non-communicable diseases (NCDs) becoming the leading cause of death worldwide. As such, aging is the second most pressing challenge facing humanity after climate change.
Hevolution Foundation is the first non-profit to pursue age-related therapeutic breakthroughs with a commitment to funding global scientific discovery, and investing in private companies and entrepreneurs who are dedicated to advancing aging science. Through the acceleration of science, we can decelerate aging and its consequences.
Changing Accepted Views
The world doesn’t yet see aging as a treatable medical, scientific, and biological condition. We’ve been encouraged to accept that aging means decline. Changing this view is our opportunity to transform the acceptance of age-related health decline into a courageous drive to put world-class resources and talent toward extending healthspan.
We must move from reactive amelioration to proactive prevention. We must engage not only individual scientists and entrepreneurs, but also private and public sector organizations and institutions worldwide. Finally, we must work across geographies and disciplines in a way that is equitable, scalable, and responsible.
Building New Incentives
To encourage the best and brightest talent, we need a genuine, independent and global set of incentives for researchers, academic institutions, professional organizations, entrepreneurs and governments. Our day-to-day work is in building, promoting, and protecting these incentives.
Lessons of COVID
COVID-19 revealed that the elderly, especially those with pre-existing chronic conditions, are among the most vulnerable and at risk in society. However, it also demonstrated that with alignment and incentives, scientists can achieve medical breakthroughs that were previously thought impossible.
To mobilize great talent, we need the same razor-sharp focus, discipline and support for new approaches and therapies.
A Transparent Global Organization
Hevolution was founded to make these great leaps forward possible. As a non-profit organization devoted to collaboration and sharing information, we seek to democratize science and knowledge, by creating partnerships, offering grants, and making investments in the longevity space.
Our highly experienced management team is assembling a staff of elite scientists, clinicians, grant experts and investment professionals, and is guided by a Board of Trustees and advisory panels comprising thought-leaders from all over the world.
We are dedicated to supporting cutting-edge, peer-reviewed science, particularly applied research, focused on accelerating therapeutic approaches to aging, including drug discovery and delivery in key areas of biology that underpin aging. We are able to fund science to a larger scale and with longer investment horizons than traditional venture capital, and with a more commercial mindset than traditional academic research.
Balancing Funding, Scientific Integrity, and Regional Priorities.
Our initial funding comes from a variety of donors, including the government of Saudi Arabia. Our annual budget of up to $1 billion USD enables us to accelerate science and bring therapies to the market.
We aim to work closely with global entities and research centres that share the same mission and objectives.
Global success depends upon global collaboration, which lies at the heart of our mandate.
There is evidence that Gulf Cooperation Council (GCC) populations are aging faster biologically than they are chronologically. Despite the region having one of the youngest populations in the world, its people are experiencing higher mortality from chronic conditions like heart disease and diabetes. Hevolution’s goal is healthspan equity and we will devote the resources needed to achieve it. This region, with its history of generating founding principles in science and medicine, yet suffering from significant age-related risks, presents a strong case to be the catalyst for healthspan transformation worldwide.
Giving Aging a Better Future
Today marks a hugely exciting milestone for our global team which has worked tirelessly and quietly to create a Foundation that will enable and catalyze the field of geroscience.
I am thrilled to lead this visionary organization, at the start of a monumental effort to give aging a better future.
- CEO Hevolution Foundation
- CEO and Board Member. Life Biosciences was founded to advance scientific research and develop innovative new therapies to improve and extend healthy lives for everyone.
- Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo
- Dr. Khan had a distinguished medical career as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition in Minneapolis, MN.
This list is automatically updatedItems found: 20
VitaminDWiki - Middle East and Vitamin D contains
149 items in Middle East category
see also Overview Middle East and vitamin D
- Low Vitamin D is associated with dying sooner (70 studies) – meta-analysis Jan 2019
- Top 10 causes of death - low vitamin D is associated with every cause - Nov 2018
- Vitamin D - at least 4,000 IU to achieve 40-60 ng and reduce risk of early death – Holick June 2018
- Top 10 causes of death - low vitamin D is associated with every cause - Nov 2018
- 2,000 IU of Vitamin D daily to German Seniors would save 30,000 lives a year – March 2021
- Plasma vitamin D levels and vitamin D receptor polymorphisms are associated with survival of non-small cell lung cancer - 2011 corresponding author PDF
- Vitamin D Status and Risk of All-Cause and Cause-Specific Mortality in a Large Cohort: Results From the UK Biobank - OCT 2020 Low Mortality if more than 20 ng of Vitamin D (UK Biobank) – Oct 2020
- Genome-wide association study (GWAS) and risk prediction of complex disease: advances and prospects Chinese - July 2011
- Basic reproduction number and predicted trends of coronavirus disease 2019 epidemic in the mainland of China - July 2020 PDF
- Advances in applications of polygenic risk score in precision prevention - Oct 2021 Chinese PDF English PDF
China’s Regular Covid Testing to Cost 1.8% of GDP, Nomura Says
- Bloomberg if done widely in China
- " If China’s wealthiest cities, home to 30% of its population, introduced regular mass testing, the costs could amount to 0.2% of GDP over the second half of this year, "
- China GDP = 17,000 Billion dollars
- 0.2 % of China's GDP = $34 billion dollars
There have been
1359 visits to this page
Possible large Vitamin D intervention trial: Iceland, Saudi Arabia etc.
461 visitors, last modified 03 Nov, 2022,This page is in the following categories (# of items in each category)
ID Name Comment Uploaded Size Downloads 18760 Shen letter Aug 25(1) Chinese.pdf admin 03 Nov, 2022 18:26 101.04 Kb 23 18759 Shen letter Aug 25(1).pdf admin 03 Nov, 2022 18:25 39.46 Kb 24 18256 polygenic+risk+score+in+precision+prevention ENGLISH.pdf admin 07 Aug, 2022 12:26 228.69 Kb 74 18255 Advances+in+applications+of+polygenic+risk+score+in+precision+prevention.pdf admin 07 Aug, 2022 12:22 799.14 Kb 65 18254 Basic reproduction number_CompressPdf.pdf admin 07 Aug, 2022 02:45 580.90 Kb 63 18253 Vit D cause mortality Biobank.pdf admin 07 Aug, 2022 02:38 950.21 Kb 51 18252 Vit D and VDR and non-small lung cancel.pdf admin 07 Aug, 2022 02:37 693.30 Kb 66 18177 9th rule in China.jpg admin 25 Jul, 2022 01:29 262.46 Kb 233 18138 SA EMR March 2022.pdf PDF 2022 admin 19 Jul, 2022 19:32 514.43 Kb 84 18137 EMR SA Feb 2022.pdf PDF 2022 admin 19 Jul, 2022 19:27 297.14 Kb 81 18136 EMR SA_CompressPdf.pdf PDF 2020 admin 19 Jul, 2022 19:21 296.02 Kb 72
- There have been